Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS)

Sponsor
H. Lee Moffitt Cancer Center and Research Institute (Other)
Overall Status
Recruiting
CT.gov ID
NCT06001268
Collaborator
United States Department of Defense (U.S. Fed)
80
1
2
47.6
1.7

Study Details

Study Description

Brief Summary

The purpose of the study is to assess the feasibility and participant satisfaction with the Support through Remote Observation and Nutrition Guidance program. The program provides enhanced dietician access and nutrition support for participants living with pancreatic cancer who are undergoing surgery.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Fitbit Data Collection
  • Behavioral: Nutrition Counseling
  • Behavioral: Survey
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Support Through Remote Observation and Nutrition Guidance Program for Individuals With Pancreatic Cancer Undergoing Surgery (STRONG-PCS)
Actual Study Start Date :
Aug 14, 2023
Anticipated Primary Completion Date :
Aug 1, 2027
Anticipated Study Completion Date :
Aug 1, 2027

Arms and Interventions

Arm Intervention/Treatment
Experimental: STRONG-PCS Intervention

Participants will receive an initial in-person consultation with a dietician within 2 weeks of hospital discharge. Then participants will receive individually tailored, bi-weekly nutrition counseling from a dietician via telehealth or in person and remote monitoring through a smart phone app and wearable sensor to allow participants to log food intake while sharing their data with a dietician.

Behavioral: Fitbit Data Collection
Participants will log food intake while sharing their data with a dietician in real time for 12 weeks

Behavioral: Nutrition Counseling
Participants will receive individually tailored, bi-weekly nutrition counseling from a dietician via telehealth or in person.

Behavioral: Survey
Participants will take a survey at baseline and weeks 4,8,& 12. (FACT-G) Questionnaire includes questions about participant's physical, social, emotional and functional well being over the past 7 days. This questionnaire uses a 5 point Likert-type scale, 0=not at all, 4=very much. A higher total score indicates better quality of life.

Active Comparator: Usual Care

Participants will be referred for nutrition counseling from a dietitian based on clinical discretion.

Behavioral: Nutrition Counseling
Participants will receive individually tailored, bi-weekly nutrition counseling from a dietician via telehealth or in person.

Behavioral: Survey
Participants will take a survey at baseline and weeks 4,8,& 12. (FACT-G) Questionnaire includes questions about participant's physical, social, emotional and functional well being over the past 7 days. This questionnaire uses a 5 point Likert-type scale, 0=not at all, 4=very much. A higher total score indicates better quality of life.

Outcome Measures

Primary Outcome Measures

  1. Recruitment Rate - Feasibility [Up to 48 months]

    The study will be deemed feasible if ≥ 50% of eligible participants are enrolled.

  2. Retention Rate - Feasibility [at 8 weeks]

    The study will be deemed feasible if ≥ 70% of participants enrolled at baseline will be retained at 8 weeks.

  3. Data Collection - Feasibility [at 8 weeks]

    The study will be deemed feasible if ≥ 70% of participants log food for greater than 80% of study days.

  4. Participant Satisfaction - Acceptability [at 8 weeks]

    The study will be deemed acceptable if ≥ 70% of participants rate the overall intervention as satisfactory using a validated 4-item scale (score range 0-20, score >/= 12).

  5. Participant Rating on Ease of Use the Mobile Application - Usability [at 8 weeks]

    The study will be deemed usable if ≥ 60% of participants rate the mobile application as easy-to-use for logging dietary intake using a validated 10-item scale (score range from 0-100, score of >/=60).

Secondary Outcome Measures

  1. Malnutrition-Significant weight loss [90 days]

    Significant weight loss is defined as >5% and >10% of body weight at 30, 60, and 90 days after discharge. This will be calculated based on weight obtained during clinic visits.

  2. Malnutrition - Low BMI [at Baseline, 30, 60 and 90 days]

    Low BMI will be defined as <20kg/m² for individuals <70 years old and <22kg/m2 for individuals ≥70 years old. This will be calculated based on weight and height measurements from clinic visits.

  3. Malnutrition - Low Skeletal Muscle Mass [At baseline, 30, 60 and 90 days]

    Low muscle mass will be estimated by calculating skeletal muscle index (SMI) from routinely collected CT scans at baseline and 90 days after discharge (CT scans are conducted every 3 months). Low muscle mass will be defined as SMI ≤38.9 cm2 /m2 for females and SMI ≤55.4 cm2 /m2 for males.

  4. Quality of Life [at Baseline, 4, 8 and 12 weeks]

    Quality of Life will be measured using the Functional Assessment of Cancer Therapy - General (FACT-G) Questionnaire includes questions about the participant's physical, social, emotional and functional well being over the past 7 days. This questionnaire uses a 5 point Likert-type scale, 0=not at all, 4=very much. A higher score indicates a better quality of life.

  5. Hospital Readmissions [30, 60 and 90 days post-hospital discharge]

    Hospital readmissions will be measured using a self-reported survey item to determine whether the patient was admitted to the index hospital or another hospital after hospital discharge.

  6. Malnutrition -Nutritional Status [at Baseline, 30, 60 and 90 days]

    Nutritional status will be measured using the Patient-Generated Subjective Global Assessment (PG-SGA) Short Form (score range: 0-35) and categorized based on a prior validation study (0-1 well nourished, 2-8 at-risk, = 9 severely malnourished).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • ≥18 years old

  • Diagnosis of pancreatic cancer

  • Completed open pancreatic surgery (e.g., Whipple, distal/subtotal pancreatectomy, total pancreatectomy) for treatment at Moffitt Cancer Center

  • Discharged on an oral diet

  • Able to speak and read English or Spanish

  • Able to provide informed consent

Exclusion Criteria:
  • Determined to be ineligible for surgery during evaluation (e.g., cancer metastasis)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Moffitt Cancer Center Tampa Florida United States 33612

Sponsors and Collaborators

  • H. Lee Moffitt Cancer Center and Research Institute
  • United States Department of Defense

Investigators

  • Principal Investigator: Kea Turner, PhD, Moffitt Cancer Center
  • Principal Investigator: Pamela J Hodul, MD, Moffitt Cancer Center

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
H. Lee Moffitt Cancer Center and Research Institute
ClinicalTrials.gov Identifier:
NCT06001268
Other Study ID Numbers:
  • MCC-22476
First Posted:
Aug 21, 2023
Last Update Posted:
Aug 21, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by H. Lee Moffitt Cancer Center and Research Institute
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 21, 2023